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LETTERS TO THE EDITOR
Hypertension and the Prothrombotic State
We read with interest the report by Pini et al. (1) that stated
patients with isolated systolic hypertension had a higher prevalence
of cardiac hypertrophy and carotid atherosclerosis than did those
with diastolic hypertension. Indeed, hypertensive left ventricular
hypertrophy is the most evident manifestation of hypertensive
target organ damage, and such patients are at particularly high risk
for strokes and heart attacks. We would like to propose an
additional interpretation of their important observations.
Despite the vessels being exposed to high pressures, the main
complications of hypertension (strokes, myocardial infarction) are,
paradoxically, thrombotic rather than hemorrhagic — the so-called
thrombotic paradox of hypertension or the Birmingham paradox
(2). The findings by Pini et al. (1) would actually strengthen our
view that hypertension confers a prothrombotic or hypercoagulable
state by fulfilling the three different components of Virchow’s triad
for thrombogenesis. With regard to the latter, there ought to be
changes in the blood flow, changes in the vessel wall, and changes
in the blood constituents, for increased thrombogenesis. “Abnor-
mal flow” is evident in hypertension, with blood vessels exposed to
blood flow under high pressures, as well as abnormal coronary flow
reserve and microcirculatory changes (3). We had previously
reported abnormalities in prothrombotic factors, endothelial func-
tion, and platelet activation in patients with isolated systolic
hypertension, comparable to that observed with systolic–diastolic
hypertension (3–5).
The study by Pini et al. (1) certainly confirms the presence of
“vessel wall abnormalities” with the high prevalence of cardiac
hypertrophy and carotid atherosclerosis. Furthermore, hyperten-
sive patients with target organ damage (5) show evidence sugges-
tive of an even greater prothrombotic state, which would contrib-
ute to the high risk of vascular complications in such patients.
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REPLY
I have read the interesting letter by Profs. Nadar and Lip. Their
speculation on the results of our study adds an additional inter-
pretation of our data. However, our study focused on cardiac and
vascular remodeling rather than on prothrombotic factors; thus,
because we did not analyze whether isolated systolic hypertension
was associated with direct evidence of a prothrombotic state we
cannot provide substantive comments on the interesting specula-
tions of Profs. Nadar and Lip.
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Questions Remain Regarding
Patients With Aortic Stenosis
and Severe Pulmonary Hypertension
Malouf et al. (1) have presented data in an uncommon but
clinically important subgroup of patients with severe aortic stenosis
and severe pulmonary hypertension. In their study, one subgroup
of patients had aortic valve replacement and another was treated
medically. The data are very interesting and important.
However, to understand fully the study groups and their
outcomes, the investigators need to present additional information
about the two subgroups:
1. How was left ventricular ejection fraction measured?
2. What was the actual calculated pulmonary artery systolic
pressure (PASP) (mean  SD, and range)?
3. What were the number and percentage of patients who under-
went selective coronary arteriography? Of those who underwent
coronary arteriography, what were the number and percentage
who had significantly obstructive coronary artery disease? Also,
did all patients with significantly obstructive coronary artery
disease have coronary bypass graft surgery? It should be noted
that the mean patient age was 78  8 years.
4. What was the five-year survival, including operative mortality
(mean  SE) and the p value for the difference in survival?
These investigators are to be congratulated on this valuable
study in a group of patients in whom additional data were needed.
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